Selected research
Industry Research
Cyanocobalamin API Industry Research Report 2026
Market perspective
The global Cyanocobalamin API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cyanocobalamin API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cyanocobalamin API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cyanocobalamin API include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cyanocobalamin API market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cyanocobalamin API Market by Company
Sanofi
Kingvit
North China Pharmaceutical Group
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
GlaxoSmithKline
Wockhardt
Rochem International
EuroAPI
Bristol Myers Squibb
Basic Nutrition
Antibiotice
Cyanocobalamin API Segment by Type
Crystal
Powder
Cyanocobalamin API Segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Cyanocobalamin API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyanocobalamin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyanocobalamin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Crystal
- Powder
Applications
- Contract Manufacturing Organizations
- Pharmaceutical Companies
- Others
Companies covered
- Sanofi
- Kingvit
- North China Pharmaceutical Group
- Hebei Yuxing Bio-Engineering
- Hebei Huarong Pharmaceutical
- GlaxoSmithKline
- Wockhardt
- Rochem International
- EuroAPI
- Bristol Myers Squibb
- Basic Nutrition
- Antibiotice
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cyanocobalamin API Market Size (2021-2032)
- 2.2.2 Global Cyanocobalamin API Sales (2021-2032)
- 2.2.3 Global Cyanocobalamin API Market Average Price (2021-2032)
- 2.3 Cyanocobalamin API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Crystal
- 2.3.3 Powder
- 2.4 Cyanocobalamin API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Contract Manufacturing Organizations
- 2.4.3 Pharmaceutical Companies
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cyanocobalamin API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cyanocobalamin API Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cyanocobalamin API Revenue of Manufacturers (2021-2026)
- 3.4 Global Cyanocobalamin API Average Price by Manufacturers (2021-2026)
- 3.5 Global Cyanocobalamin API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cyanocobalamin API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cyanocobalamin API, Product Type & Application
- 3.8 Global Manufacturers of Cyanocobalamin API, Established Date
- 3.9 Global Cyanocobalamin API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Cyanocobalamin API Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Kingvit
- 4.2.1 Kingvit Company Information
- 4.2.2 Kingvit Business Overview
- 4.2.3 Kingvit Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kingvit Cyanocobalamin API Product Portfolio
- 4.2.5 Kingvit Recent Developments
- 4.3 North China Pharmaceutical Group
- 4.3.1 North China Pharmaceutical Group Company Information
- 4.3.2 North China Pharmaceutical Group Business Overview
- 4.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
- 4.3.5 North China Pharmaceutical Group Recent Developments
- 4.4 Hebei Yuxing Bio-Engineering
- 4.4.1 Hebei Yuxing Bio-Engineering Company Information
- 4.4.2 Hebei Yuxing Bio-Engineering Business Overview
- 4.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
- 4.4.5 Hebei Yuxing Bio-Engineering Recent Developments
- 4.5 Hebei Huarong Pharmaceutical
- 4.5.1 Hebei Huarong Pharmaceutical Company Information
- 4.5.2 Hebei Huarong Pharmaceutical Business Overview
- 4.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
- 4.5.5 Hebei Huarong Pharmaceutical Recent Developments
- 4.6 GlaxoSmithKline
- 4.6.1 GlaxoSmithKline Company Information
- 4.6.2 GlaxoSmithKline Business Overview
- 4.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
- 4.6.5 GlaxoSmithKline Recent Developments
- 4.7 Wockhardt
- 4.7.1 Wockhardt Company Information
- 4.7.2 Wockhardt Business Overview
- 4.7.3 Wockhardt Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Wockhardt Cyanocobalamin API Product Portfolio
- 4.7.5 Wockhardt Recent Developments
- 4.8 Rochem International
- 4.8.1 Rochem International Company Information
- 4.8.2 Rochem International Business Overview
- 4.8.3 Rochem International Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rochem International Cyanocobalamin API Product Portfolio
- 4.8.5 Rochem International Recent Developments
- 4.9 EuroAPI
- 4.9.1 EuroAPI Company Information
- 4.9.2 EuroAPI Business Overview
- 4.9.3 EuroAPI Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 EuroAPI Cyanocobalamin API Product Portfolio
- 4.9.5 EuroAPI Recent Developments
- 4.10 Bristol Myers Squibb
- 4.10.1 Bristol Myers Squibb Company Information
- 4.10.2 Bristol Myers Squibb Business Overview
- 4.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
- 4.10.5 Bristol Myers Squibb Recent Developments
- 4.11 Basic Nutrition
- 4.11.1 Basic Nutrition Company Information
- 4.11.2 Basic Nutrition Business Overview
- 4.11.3 Basic Nutrition Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
- 4.11.5 Basic Nutrition Recent Developments
- 4.12 Antibiotice
- 4.12.1 Antibiotice Company Information
- 4.12.2 Antibiotice Business Overview
- 4.12.3 Antibiotice Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Antibiotice Cyanocobalamin API Product Portfolio
- 4.12.5 Antibiotice Recent Developments
5 Global Cyanocobalamin API Market Scenario by Region
- 5.1 Global Cyanocobalamin API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cyanocobalamin API Sales by Region: 2021-2032
- 5.2.1 Global Cyanocobalamin API Sales by Region: 2021-2026
- 5.2.2 Global Cyanocobalamin API Sales by Region: 2027-2032
- 5.3 Global Cyanocobalamin API Revenue by Region: 2021-2032
- 5.3.1 Global Cyanocobalamin API Revenue by Region: 2021-2026
- 5.3.2 Global Cyanocobalamin API Revenue by Region: 2027-2032
- 5.4 North America Cyanocobalamin API Market Facts & Figures by Country
- 5.4.1 North America Cyanocobalamin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cyanocobalamin API Sales by Country (2021-2032)
- 5.4.3 North America Cyanocobalamin API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cyanocobalamin API Market Facts & Figures by Country
- 5.5.1 Europe Cyanocobalamin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cyanocobalamin API Sales by Country (2021-2032)
- 5.5.3 Europe Cyanocobalamin API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cyanocobalamin API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cyanocobalamin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cyanocobalamin API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cyanocobalamin API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cyanocobalamin API Market Facts & Figures by Country
- 5.7.1 South America Cyanocobalamin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cyanocobalamin API Sales by Country (2021-2032)
- 5.7.3 South America Cyanocobalamin API Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cyanocobalamin API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cyanocobalamin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cyanocobalamin API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cyanocobalamin API Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cyanocobalamin API Sales by Type (2021-2032)
- 6.1.1 Global Cyanocobalamin API Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cyanocobalamin API Sales Market Share by Type (2021-2032)
- 6.2 Global Cyanocobalamin API Revenue by Type (2021-2032)
- 6.2.1 Global Cyanocobalamin API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cyanocobalamin API Revenue Market Share by Type (2021-2032)
- 6.3 Global Cyanocobalamin API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cyanocobalamin API Sales by Application (2021-2032)
- 7.1.1 Global Cyanocobalamin API Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cyanocobalamin API Sales Market Share by Application (2021-2032)
- 7.2 Global Cyanocobalamin API Revenue by Application (2021-2032)
- 7.2.1 Global Cyanocobalamin API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cyanocobalamin API Revenue Market Share by Application (2021-2032)
- 7.3 Global Cyanocobalamin API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cyanocobalamin API Value Chain Analysis
- 8.1.1 Cyanocobalamin API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cyanocobalamin API Production Mode & Process
- 8.2 Cyanocobalamin API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cyanocobalamin API Distributors
- 8.2.3 Cyanocobalamin API Customers
9 Global Cyanocobalamin API Analyzing Market Dynamics
- 9.1 Cyanocobalamin API Industry Trends
- 9.2 Cyanocobalamin API Industry Drivers
- 9.3 Cyanocobalamin API Industry Opportunities and Challenges
- 9.4 Cyanocobalamin API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst